We finally found the exact 'molecular bridge' that turns a common virus into Multiple Sclerosis.
April 15, 2026
Original Paper
A Genetically Driven Immunologic Mechanism Underlying the Link between EBV and Multiple Sclerosis
medRxiv · 10.64898/2025.12.11.25342083
The Takeaway
Scientists have known for a while that the Epstein-Barr Virus (EBV) is linked to Multiple Sclerosis, but they didn't know exactly why. This study finally identified the 'smoking gun': when EBV infects specific immune cells, it flips a switch on genetic risk genes that people are born with. This 'bridge' triggers an autoimmune attack on the brain that leads to MS. It’s a perfect storm of a common virus meeting a specific genetic vulnerability. This discovery could pave the way for a vaccine or treatment that prevents MS from ever developing in high-risk individuals. We're finally closing the gap between a common infection and a life-changing disease.
From the abstract
Epstein-Barr virus (EBV) is implicated as a trigger of multiple sclerosis (MS), yet the host genetic mechanisms linking EBV activity to MS is unknown. We performed a cross-ancestry genome-wide association study of EBV DNA positivity (N=617,186), identifying 39 susceptibility risk loci that significantly overlapped with MS risk genes (p=1.3x10-12). Using our single-cell method for EBV detection, we identified 1,069 EBV-infected B cells across 38 individuals. EBV was predominantly in the latent ph